In preclinical research dating back to the 1990s, BPC-157 has demonstrated remarkable effects across multiple body systems
Keep Things Moving GLP-1s can slow digestion, and travel can make this even more noticeable
In a STEP-UP trial study, after 72 weeks of a 7.2 mg dose, nearly half of people had dropped 20% or more of their starting weight
Estos nuevos frmacos llegan a alcanzar valores medios de prdida de peso del 24%, lo que contribuye a su eficacia sobre las complicaciones de la obesidad
Struggling with weight and health issues
The paper Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: a multicenter prospective observational study was authored by Yuya Koide, Takehiro Kato, Makoto Hayashi, Hisashi Daido, Takako Maruyama, Takuma Ishihara, Kayoko Nishimura, Shin Tsunekawa, and Daisuke Yabe on behalf of G-DIET Investigators